Peter H. Vlasses

Effects of Finasteride (MK-906), a 5<i>α</i>-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*

Glenn J. Gormley, Elizabeth Stoner, Roger S. Rittmaster et al. · The Journal of Clinical Endocrinology & Metabolism · 1990 · 161 citations

Norfloxacin disposition after sequentially increasing oral doses

B N Swanson, V K Boppana, Peter H. Vlasses et al. · Antimicrobial Agents and Chemotherapy · 1983 · 147 citations · Full text

Drug Analysis, Pharmacological Study, Norfloxacin Disposition +12

Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease

Anatole Besarab, Kristen K. Flaharty, A. J. Erslev et al. · Journal of the American Society of Nephrology · 1992 · 140 citations · Full text

Dose Response, Dialysis Therapy, Pharmacotherapy +19

Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men

Kristen K. Flaharty, Allan J. Erslev, John J. Whalen et al. · Clinical Pharmacology & Therapeutics · 1990 · 126 citations

Effects of Gender, Posture, and Age on Gastric Residence Time of an Indigestible Solid: Pharmaceutical Considerations

Parviz Mojaverian, Peter H. Vlasses, Paul E. Kellner et al. · Pharmaceutical Research · 1988 · 117 citations